[The second life of daptomycin: analysis of a successful come-back]

Med Mal Infect. 2008 Dec:38 Spec No 2:1-3. doi: 10.1016/S0399-077X(08)75150-3.
[Article in French]
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Daptomycin / adverse effects
  • Daptomycin / pharmacology
  • Daptomycin / therapeutic use*
  • Drug Therapy / trends
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / microbiology
  • Gram-Positive Bacterial Infections / drug therapy*
  • Humans
  • Methicillin Resistance
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Muscular Diseases / chemically induced
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects
  • Vancomycin Resistance

Substances

  • Anti-Bacterial Agents
  • Daptomycin